MCM
DTIL icon

MAI Capital Management’s Precision BioSciences DTIL Stock Holding History

MAI Capital Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39 Hold
7
– – ﹤0.01% 4899
2025
Q4 		$30 Hold
7
– – ﹤0.01% 4280
2025
Q3 		$39 Hold
7
– – ﹤0.01% 3767
2025
Q2 		$30 Hold
7
– – ﹤0.01% 3925
2025
Q1 		$34 Hold
7
– – ﹤0.01% 3398
2024
Q4 		$27 Buy
+7
New +$51 ﹤0.01% 3462

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

MAI Capital Management's DTIL Position: Q1 2026 in Review

MAI Capital Management held its Precision BioSciences (DTIL) position steady in Q1 2026 at 7 shares worth $39. The position accounts for ﹤0.01% of the portfolio, ranked #4899.

MAI Capital Management first reported a position in DTIL in Q4 2024 and has held it in 6 quarters since. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • MAI Capital Management held 7 shares of Precision BioSciences worth $39 as of Q1 2026.
  • MAI Capital Management left its Precision BioSciences share count unchanged in Q1 2026.
  • Precision BioSciences made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #4899 holding.
  • MAI Capital Management first reported a position in Precision BioSciences in Q4 2024 and has held it in 6 quarters since.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.